Comparison between on-label versus off-label use of drug-eluting coronary stents in clinical practice: results from the German DES.DE-Registry

Show other versions (1)

Observational studies from the USA have demonstrated that off-label use of drug-eluting stents (DES) is common. Data on off-label use in Western Europe are limited.

Saved in:

Bibliographic Details
Main Authors:	Bauer, Timm (Author) , Nienaber, Christoph A. (Author) , Akın, Ibrahim (Author) , Kuck, Karl-Heinz (Author) , Hochadel, Matthias (Author) , Senges, Jochen (Author) , Fetsch, Thomas (Author) , Tebbe, Ulrich (Author) , Willich, Stefan N. (Author) , Stumpf, Jürgen (Author) , Sabin, Georg V. (Author) , Silber, Sigmund (Author) , Richardt, Gert (Author) , Zahn, Ralf (Author)
Format:	Article (Journal)
Language:	English
Published:	18 March 2011
In:	Clinical research in cardiology Year: 2011, Volume: 100, Issue: 8, Pages: 701-709
ISSN:	1861-0692
DOI:	10.1007/s00392-011-0301-8
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00392-011-0301-8
Author Notes:	Timm Bauer, Christoph A. Nienaber, Ibrahim Akin, Karl-Heinz Kuck, Matthias Hochadel, Jochen Senges, Thomas Fetsch, Ulrich Tebbe, Stefan N. Willich, Jürgen Stumpf, Georg V. Sabin, Sigmund Silber, Gert Richardt, Ralf Zahn for the DES.DE Study Group

Description
Summary:	Observational studies from the USA have demonstrated that off-label use of drug-eluting stents (DES) is common. Data on off-label use in Western Europe are limited.
Item Description:	Gesehen am 03.03.2022
Physical Description:	Online Resource
ISSN:	1861-0692
DOI:	10.1007/s00392-011-0301-8